The ANGIO-SEAL VIP Vascular Closure Device is designed to achieve rapid, reliable hemostasis following diagnostic or interventional femoral artery access. It creates an active mechanical seal from inside the artery using a bioabsorbable polymer anchor, collagen plug, and connecting suture. Clinical data demonstrates a 99.7% deployment success rate and 97.8% hemostasis rate by the device alone. All components are fully absorbed within 60-90 days post-implantation, with the anchor beginning to hydrate and soften within 24-36 hours. It is indicated for earliest ambulation following both diagnostic and interventional procedures and supports same-day discharge protocols.

Terumo Corporation
Global leader in cardiovascular, interventional, and infusion therapy solutions.